Dose Reduction of Baricitinib in Patients with Rheumatoid Arthritis Achieving Sustained Disease Control: Results of a Prospective Study
Ann Rheum Dis. 2019 Feb;78(2):171-178. DOI 10.1136/annrheumdis-2018-213271
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis. 2019 Feb;78(2):171-178. DOI 10.1136/annrheumdis-2018-213271
J Rheumatol. 2019 Jan;46(1):7-18. DOI: 10.3899/jrheum.171361
Ann Rheum Dis. 2018 Jul;77(7):988-995. DOI 10.1136/annrheumdis-2017-212461
RMD Open. 2018 May 8;4(1):e000662. DOI: 10.1136/rmdopen-2018-000662
Rheumatology (Oxford) 2018 May; 57(5):900-908
Arthritis Res Ther. 2017 Sep 18;19(1):208
Ann Rheum Dis 2017;76(11):1853-1861. doi: 10.1136/annrheumdis-2017-211259
J Rheumatol. 2018 Jan;45(1):14-21. doi: 10.3899/jrheum.161161
Ann Rheum Dis 2017;76:88–95.
Arthritis Rheumatol 2016. DOI 10.1002/art.39953. Accepted article